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Regulators of transferrin uptake <p>A survey of 1,804 human dicer-generated signaling siRNAs using automated quantitative imaging identified the phosphatidylinositol- 3,4,5-trisphosphate-mTOR signaling pathway as a primary regulator of iron-transferrin uptake.</p>
Abstract
Background: Iron uptake via endocytosis of iron-transferrin-transferrin receptor complexes is a
rate-limiting step for cell growth, viability and proliferation in tumor cells as well as non-
transformed cells such as activated lymphocytes. Signaling pathways that regulate transferrin uptake
have not yet been identified.
Results: We surveyed the human signaling proteome for regulators that increase or decrease
transferrin uptake by screening 1,804 dicer-generated signaling small interfering RNAs using
automated quantitative imaging. In addition to known transport proteins, we identified 11 signaling
proteins that included a striking signature set for the phosphatidylinositol-3,4,5-trisphosphate
(PtdIns(3,4,5)P3)-target of rapamycin (mTOR) signaling pathway. We show that the PI3K-mTOR
signaling pathway is a positive regulator of transferrin uptake that increases the number of
transferrin receptors per endocytic vesicle without affecting endocytosis or recycling rates.
Conclusion: Our study identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a new regulator
of iron-transferrin uptake and serves as a proof-of-concept that targeted RNA interference screens
of the signaling proteome provide a powerful and unbiased approach to discover or rank signaling
pathways that regulate a particular cell function.
Background
Iron is an essential nutrient that functions as a co-factor for
enzymes that perform single electron oxidation-reduction
reactions [1,2]. Intracellular iron deficiency leads to cell cycle
arrest in G1 phase and apoptosis [3,4], whereas an excess of
cytosolic iron causes oxidative stress and necrosis through
the production of reactive oxygen species [5]. Since neither
iron deficiency nor excess are tolerated by cells, iron uptake
and consumption must be tightly coordinated. Nearly all
extracellular iron is bound to transferrin and uptake of iron-
loaded transferrin is mediated primarily by the transferrin
receptor (also named TfR1 or TFRC), which is internalized by
clathrin-mediated endocytosis [6]. Iron is released from
transferrin in the acidic endosomal environment and reaches
the cytosol via divalent metal transporter 1 [2,7]. Transferrin
and its receptor recycle back to the cell surface where
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transferrin dissociates and is used for further cycles of iron
binding and uptake (Figure 1a). There are three main deter-
minants for transferrin and iron uptake: the rate of receptor
internalization (kendo), the rate of recycling (kexo), and the
total number of transferrin receptors involved in the endo-
cytic cycle (Figure 1a). Here we performed a targeted small
interfering RNA (siRNA) screen of the human signaling pro-
teome to identify signaling molecules and pathways that reg-
ulate transferrin uptake and can thereby limit iron availability
and cell growth.
Results and discussion
A transferrin uptake siRNA screen of the human 
signaling proteome
We developed a functional genomic approach to survey the
human signaling proteome and identify potential signaling
pathways controlling transferrin uptake. Increases or
decreases in the rate of transferrin uptake were detected by
monitoring the endosomal concentration of fluorescent
transferrin using automated and quantitative high-through-
put imaging. We applied automated image processing to
measure the fluorescence intensity of perinuclear recycling
endosomes in hundreds of individual cells per well of a 96-
Automated image-based quantification of iron-loaded transferrin uptake in HeLa cells Figure 1
Automated image-based quantification of iron-loaded transferrin uptake in HeLa cells. (a) Schematic representation of the transferrin-mediated iron 
uptake system. Transferrin receptors (TFRC, grey ovals) cycle between the plasma membrane (PM) and the endosomal recycling compartment (ERC) 
using vesicular carrier (black circles). Iron (Fe3+, blue circles) binds to TFRC at the cell surface and is released into the ERC. At the steady-state, the 
quantity of internalized transferrin depends on the rate of transferrin endocytosis (kendo), the rate of transferrin recycling (kexo), and on the total number 
of cycling transferrin receptors. (b) Fluorescent transferrin uptake in mock-transfected HeLa cells (red). Hoechst-stained nuclei (blue) were used to 
segment the images and create the perinuclear regions (yellow) used to measure the fluorescence intensity in the 'red' channel. (c) Histogram of single cell 
fluorescence intensities (the median (F) is the transferrin uptake index used in this study). (d) Time-course of fluorescent transferrin uptake (red circles) 
and recycling (blue circles). The dashed line indicates the time point chosen for the screen. Means ± standard error of the mean (n = 4 replicates). (e) 
Images and quantification of fluorescent transferrin uptake in cells transfected with d-siRNAs targeting GL3 luciferase (CTR), the μ2 subunit of the AP2 
adapter (AP2M1) or the clathrin heavy chain (CLTC). Means ± standard error of the mean (n = 3 experiments). Scale bars, 10 μm.
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well plate (Figure 1b). The median of the measured single cell
fluorescence intensity values (F) in a well was used as a
measure of transferrin uptake (Figure 1c). This quantification
was sufficiently sensitive to measure the time-course of trans-
ferrin uptake and recycling (Figure 1d), as well as to detect
expected decreases in transferrin uptake when we knocked
down elements of the endocytic machinery, μ2 subunit of the
AP2 adaptor (AP2M1) or clathrin heavy chain (CLTC), using
diced pools of siRNA (Figure 1e). The coefficient of variation
of the measured uptake values in a 96-well plate format was
less than 5% (Figure S1 in Additional data file 1).
In order to probe the signaling pathways that may regulate
transferrin uptake, we generated a library of diced siRNAs (d-
siRNA) that included a comprehensive set of 1,920 genes
from the predicted human signaling proteome (see Addi-
tional data file 2 for the complete list of the targeted genes).
Targeted gene products were selected based on their signaling
domain content, for example, kinase, SH2, PH, or PDZ
domains, as well as descriptive key words, such as signal
transduction, endocytosis and exocytosis, as annotated by the
National Center for Biotechnology Information (NCBI) Ref-
seq and Conserved Domains (CDD) databases (Figure 2a;
Additional data file 2). Components of canonical signaling
pathways were included (for example, Ca2+, cAMP, and ERK),
as well as less characterized and putative signaling proteins
and pathways (Figure 2b). We also targeted a number of spe-
cific vesicular transport-associated proteins expected to affect
transferrin trafficking, such as clathrin chains, clathrin
adapters and coat proteins, and included them as positive
controls. This signaling RNA interference (RNAi) library was
synthesized using a 96-well formatted protocol to generate
double-stranded RNAs that were digested in vitro with
recombinant human RNase III Dicer protein to produce tar-
get specific d-siRNA pools [8] (see Figure S2 in Additional
data file 1 for an illustration of the method). Amongst the ini-
tial 1,920 d-siRNAs, 1,804 passed our quality controls (see
Materials and methods) and will be eventually considered. D-
siRNAs have been shown in previous studies to provide, in
nearly all tested cases, more than 50% knock-down of tar-
geted gene products [8-11].
Fluorescent transferrin uptake was measured in duplicate for
the 1,804 signaling d-siRNAs 60 hours after transfection. The
average of the two normalized F scores is shown for each of
the 1,804 d-siRNAs in Figure 2c. The scatter plot of the F
scores obtained from duplicated d-siRNAs shows that the
majority of hits that strongly deviated from the median were
reproducible (Figure S3 in Additional data file 1).
An important step for identifying signaling proteins and path-
ways in a siRNA screen is to decide whether a particular value
significantly deviates from the stochastic experimental noise.
We developed a tool that we call CAsH (for Confidence Anal-
ysis of siRNA Hits) that compares each measured value to the
noise distribution observed in the screen. The distribution of
the variances between the duplicate measurements was used
to evaluate the noise distribution, assuming that multiple
measurements of the same d-siRNA, whether effective hits or
not, have the same variance as repetitions of control d-siRNA
(Figure 2d). Thus, the experimental noise is directly esti-
mated from the relevant data set with no need to assay in par-
allel a large population of identical d-siRNAs. For each
average F score from each d-siRNA, the calculated CAsH
parameter then gives a probability score between -1 and 1. For
instance, an effect with a CAsH score equal to -0.90 or 0.90 is
expected to be observed 90% of the time as siRNA with sup-
pressor or activator activity, respectively. Whereas the z-
scores frequently used in siRNA screens are indicative of the
position of a given siRNA relative to the whole data set distri-
bution (therefore, their values depend on the hit content of
the library), the CAsH scores reflect the confidence that the
effect of a siRNA of interest will be observed again. Our screen
had 183 d-siRNAs that resulted in an absolute value of the
CAsH score ≥0.95. (see Additional data file 3 for the list of pri-
mary hits and Figure S4 in Additional data file 1 for the distri-
bution of the CAsH scores).
To reduce the number of false positive caused by systematic
sources of noise occurring during the screening process, the
primary hits were assayed again (using a higher concentra-
tion of d-siRNAs; 100 nM versus 20 nM). There were 154
genes (84%) that presented similar or stronger effects than
observed in the primary screen. Amongst these genes, 91 were
selected (based on consistency between replicates, quality of
the diced siRNA pools (aspect on gel) and the length of their
coding sequence (>900 base-pairs (bp) to allow the synthesis
of a second independent batch of d-siRNA; see below)) and
further assayed with a new batch of d-siRNA using the same
sequence as the one used to perform the initial screen: 71
genes (approximately 80%) showed identical results between
the two batches (Additional data file 3). Furthermore, in
order to determine whether a particular hit is caused by on-
or off-target effects, we performed another round of valida-
tion by testing a second set of d-siRNA pools that targeted a
different region of the mRNA coding sequence (Figure 2e,
and see Additional data file 6 for the nucleotide sequences of
the primers used). The probability that off-target effects were
observed for such matching pairs of d-siRNAs is predicted to
decrease with the square of the off-target rate for a single d-
siRNA (off-target rate for paired hits is estimated to be <2.5 ×
10-3; see Materials and methods). Using both sets of d-siRNAs
(at a concentration of 20 nM), we identified 21 pairs among
the 71 selected genes that showed a significant effect for both
the first and second d-siRNA pools (Figure 2f,g, and see Addi-
tional data file 4 for the list of the 21 high confidence hits).
This validation rate of 21 out of 71 is likely not a result of off-
target effects since we estimate that the upper limit for off-
target effects is 5% (see Materials and methods). Systematic
variations occurring during the d-siRNA synthesis process or
intrinsic differences of the two template regions in producingR142.4 Genome Biology 2007,     Volume 8, Issue 7, Article R142       Galvez et al. http://genomebiology.com/2007/8/7/R142
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Diced-siRNA screen of the human signaling proteome identifies regulators of transferrin uptake Figure 2
Diced-siRNA screen of the human signaling proteome identifies regulators of transferrin uptake. (a) Selected d-siRNAs include proteins with known 
signaling related domains (as named and annotated in the NCBI CDD database of 20 July 2005 [29]. Related domains were pooled in the same category 
bin). Transmembrane receptors and transcription factors were excluded. (b) Examples of signaling pathways and numbers of their components 
represented in the selected signaling proteome set. (c) Measured transferrin uptake values (F) from the human signaling proteome screen. Data sorted in 
ascending order. (d) Method to calculate hit probabilities by CAsH analysis. The histogram of the screen data (light blue) is compared to the stochastic 
noise distribution (red). CAsH values correspond to the estimated fraction of hits for each F score. (e) Regions within mRNAs selected to design the two 
independent d-siRNA pools. Seq1 corresponds to the region chosen to synthesize the initial batches of d-siRNAs, Seq2 to the region chosen to synthesize 
the second, independent batch. (f) Transferrin uptake regulators identified by two independent d-siRNA pools. (g) Genes increasing or decreasing 
transferrin uptake in HeLa cells.
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efficient d-siRNAs, might explain why only one out of two d-
siRNA pool is effective.
Identification of the mTOR pathway as primary 
signaling module controlling transferrin uptake
This set of 21 high confidence regulators of transferrin uptake
contained a striking fraction of proteins from the phosphati-
dylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3)-target of
rapamycin (mTOR) signaling pathway [12] (Figure 3a). Two
of these proteins, TSC2 and PTEN, are known mTOR sup-
pressors whose knock-down enhances transferrin uptake.
Three others (PDK1, alias PDPK1, AKT1, and mTOR, alias
FRAP1) are known activators whose knock-down reduces
transferrin uptake (Figure 2f). We call such a match of the
players, as well as of the direction of the effects, a signature of
a particular signaling pathway. In addition to signature pro-
teins of the PtdIns(3,4,5)P3-mTOR pathway, the other hits
could be grouped into a set of miscellaneous putative signal-
ing proteins that included three protein phosphatases, a PKA
regulatory subunit, a cytoskeletal associated protein,
PLEKHC1 [13], as well as TAOK2 [14], which has been pro-
posed to be involved in p38 mitogen-activated protein kinase
signaling. A third identified group included components and
regulators of the vesicular trafficking and endocytosis
machinery (Figure 2g, Additional data file 4).
We performed additional experiments to verify that the iden-
tified d-siRNAs do act on the PtdIns(3,4,5)P3-mTOR path-
way and to investigate whether mTOR signaling
preferentially regulates uptake of transferrin. When we com-
pared the effect of d-siRNA pools and synthetic siRNAs, we
found that knocking-down the identified activators of this
pathway (mTOR, PDK1, AKT1) led in both cases to a reduc-
tion of transferrin uptake, whereas knocking-down inhibitors
(TSC2, PTEN) increased uptake (Figure 3b, Figure S5a in
Additional data file 1). We also tested for the effects of two
other players in the mTOR pathway, tuberous sclerosis 1
(TSC1), which was initially not included in our d-siRNA
library, and the GTPase RHEB. TSC1 synthetic siRNA
increased transferrin uptake as did its partner TSC2, whereas
RHEB synthetic siRNA had a strong inhibitory effect on
transferrin uptake (Figure 3b). We further confirmed the
involvement of the mTOR signaling pathway by treatment
with rapamycin (20 nM for 24 hours), a small molecule inhib-
itor of mTOR [12], which reduced transferrin uptake to a sim-
ilar extent as mTOR knock-down (Figure 3b).
We then verified whether the identified d-siRNAs targeting
the PtdIns(3,4,5)P3-mTOR module interfere with mTOR sig-
naling by using phosphorylation of the ribosomal protein S6
(on Ser235/236) as a cell-based readout for mTOR activity
[15,16] (Figure 3c,d). We found marked effects on S6 protein
phosphorylation that closely corresponded to the effects on
transferrin uptake (Figure 3e). This supports the notion that
the identified genes are part of the same signaling module
that includes PtdIns(3,4,5)P3 and mTOR signaling. Taken
together, these results further argue that transferrin uptake is
under the control of the PtdIns(3,4,5)P3-mTOR signaling
pathway.
The specificity of mTOR signaling for regulating transferrin
uptake was investigated by comparing the effect of rapamycin
on uptake of transferrin, low density lipoprotein (LDL) and
epidermal growth factor (EGF) using fluorescently labeled
ligands (Figure 3f). Consistent with a preferential role of
mTOR signaling for transferrin uptake, the effect of mTOR
inhibition was significantly stronger for transferrin uptake
compared to LDL or EGF uptake.
The PI3K-mTOR pathway controls iron uptake by 
regulating the number of transferrin receptors per 
endocytic vesicle
Transferrin uptake activity is dependent on endocytic and
recycling rates (Figure 1a), and mTOR has been reported to
regulate bulk flow as well as specific forms of receptor-medi-
ated endocytosis [17]. We therefore investigated whether part
or all of the rapamycin effect on transferrin uptake could be
explained by mTOR-mediated regulation of the endocytosis
or recycling rates. A rapamycin-induced reduction in either
one of the rates would reduce the measured transferrin
uptake. While rapamycin treatment reduced the steady state
concentration of internalized endosomal transferrin (Figure
4a), neither the time constant for endocytosis nor recycling
were significantly altered by rapamycin (Figure 4b).
The lack of effect of rapamycin on the kinetics of endocytosis
and recycling suggested that most of the effect of the mTOR
pathway on transferrin uptake must result from the regula-
tion of the total concentration of transferrin receptor (Figure
1a). Earlier studies have shown that mTOR can regulate the
concentration of specific proteins and cell mass by enhancing
translation via the translation regulators S6 kinase 1 and
eIF4E-binding proteins [18,19], as well as by regulating pro-
tein degradation [20,21]. We tested whether the concentra-
tion of the transferrin receptor is affected by using an
immunofluorescence-based assay in permeabilized cells,
using transferrin receptor-specific antibodies. Targeting
mTOR with d-siRNAs caused a 20% reduction of the inte-
grated transferrin receptor fluorescence. Targeting AKT1 and
PDK1 had smaller inhibitory effects, whereas targeting TSC2
or PTEN led to an increase in the integrated transferrin recep-
tor fluorescence intensity (Figure 4c, and Figure S5b in Addi-
tional data file 1). The amplitude of the effects of different d-
siRNAs on transferrin uptake were correlated with the
number of transferrin receptors per cell, suggesting that
increases and decreases in mTOR signaling are translated
into higher and lower numbers of transferrin receptors
resulting in increased or decreased transferrin uptake (Figure
4d). As a control, knock-down of clathrin heavy chain d-siR-
NAs (CLTC), which suppresses transferrin uptake by reduc-
ing endocytosis rates, did not show the same concomitant
decrease in transferrin receptor concentration (Figure 4d).R142.6 Genome Biology 2007,     Volume 8, Issue 7, Article R142       Galvez et al. http://genomebiology.com/2007/8/7/R142
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Figure 3 (see legend on next page)
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We also confirmed that rapamycin treatment (20 nM for 24
hours) had a similar effect on the integrated transferrin
receptor fluorescence compared to the effect of mTOR d-siR-
NAs (Figure 4e). As a control, we also found that the number
of transferrin receptors is much more strongly affected by
mTOR inhibition compared to two other abundant reference
proteins, actin and tubulin (Figure 4e). This also suggested
that cell mass was only weakly affected for the conditions
used in our experiments.
The reduction in transferrin uptake and total transferrin
receptor number likely reflects a lower number of transferrin
and transferrin receptors per endocytic carrier but could also
reflect a lower number of transferrin-containing endocytic
carriers. We therefore measured the relative number of trans-
ferrin molecules per vesicle by using a texture algorithm that
integrated the total intensity of each vesicle over a local back-
ground. As shown in the histogram of the fluorescence inten-
sity of individual endocytic vesicles (Figure 4f), rapamycin
treatment induced a marked decrease in the transferrin stain-
ing per vesicle but only a relatively small decrease in the
number of endocytic vesicles (Figure 4g). Taken together, this
indicates that the PtdIns(3,4,5)P3-mTOR pathway primarily
regulates the number of transferrin receptor molecules per
endocytic vesicle rather than recycling rates or endosome
number and that this regulation is preferential for transferrin
over LDL and EGF uptake.
Conclusion
Our study identifies the PtdIns(3,4,5)P3-mTOR signaling
pathway as an important regulator of transferrin uptake, add-
ing a new function to this important regulatory system for cell
growth. The mTOR pathway is known to integrate inputs
from growth factor receptors, amino acid availability, AMP/
ATP ratio and 'stress' (hypoxia, DNA damage) and to respond
by adjusting the rate of cell growth and proliferation [12].
Since excess iron is toxic and since iron uptake is also rate-
limiting for cell growth, cells may use PtdIns(3,4,5)P3 -mTOR
regulation of transferrin uptake to reduce the toxic effect of
iron accumulation as well as to promote cell growth and pro-
liferation. Considering the critical dependence of oxygen-
based metabolism on intracellular iron concentration, these
results may also explain the reported correlation of mTOR
activity with mitochondrial oxygen consumption [22]. The
question of how mTOR regulates the number of transferrin
receptors remains open. mTOR-dependent stabilization of
Hypoxia-inducible factor-1 (HIF-1) or c-myc [21,23], both
well characterized transcriptional activators of the transferrin
receptor gene [24-28], could account for the observed effect
of mTOR activity on transferrin receptor level but other
mechanisms based on translation or protein degradation are
also plausible.
Our study provides a proof-of-concept that small human
siRNA libraries focused on the signaling proteome can serve
as powerful and unbiased genomic survey tools to discover or
rank signaling pathways that regulate a particular cell func-
tion. Here we show that the key role of an important signaling
pathway can be demonstrated from what we call a siRNA
signature that consists of multiple suppressor and activator
proteins in that pathway.
Materials and methods
Generation of diced-siRNA pools
The protocol used to synthesize d-siRNA [8] has been scaled-
up to synthesize the 1,920 d-siRNAs library as previously
reported [11]. Specific primers for each selected gene (Addi-
tional data file 5) were automatically designed and were used
to amplify from a cDNA library an approximately 600 bp PCR
fragment of the 3' region of the coding sequence. A second
amplification was performed with a set of nested primers
bearing a T7 promoter sequence on their 5' extension. Nested
PCR products with no products or products of unexpected
size (116 genes among the 1,920) were eliminated from the
analysis of the screen. Nested PCR products were transcribed
in vitro (T7 MEGA script kit, Ambion; Austin, TX, USA) and
the resulting double-stranded RNAs were annealed and proc-
essed with 30 units/reaction of human recombinant Dicer
(Invitrogen; Carlsbad, CA, USA) for 15 h at 37°C. The 21-mer
d-siRNAs were separated from incompletely digested frag-
ments using a succession of isopropanol precipitations and
filtration on glass fiber plates (Nunc; Rochester, NY, USA).
Synthetic siRNAs were from Dharmacon (Lafayette, CO,
USA).
Transfection and transferrin internalization assays
HeLa cells were plated at a density of 1,800 cells per well in
96-well plates in DMEM media supplemented with 10% fetal
bovine serum and antibiotics. The d-siRNAs (approximately
20 ng/well) in a final volume of 50 μl were transfected the fol-
The PtdIns(3,4,5)P3-mTOR signaling pathway controls transferrin uptake Figure 3 (see previous page)
The PtdIns(3,4,5)P3-mTOR signaling pathway controls transferrin uptake. (a) Schematic representation of the PtdIns(3,4,5)P3-mTOR signaling pathway. 
(b) Quantification of the effects of different siRNAs targeting the PtdIns(3,4,5)P3-mTOR pathway and rapamycin (RAPA) on transferrin uptake. Means ± 
standard error of the mean (SEM; for d-siRNAs, n = 6; for synthetic siRNAs, n = 4; for rapamycin, n = 17). (c-d) Regulation of S6 protein phosphorylation 
by the PtdIns(3,4,5)P3-mTOR targeting d-siRNAs. Immunofluorescent images compared the effect of mTOR and GL3 luciferase (CTR) knock-downs on 
phosphorylated S6 protein staining (red). Nuclei are stained with Hoechst (blue). Scale bars, 10 μm. Quantification of the staining-associated average 
fluorescence intensity (d). Means ± SEM (n = 6). (e) Correlation between the effect of d-siRNAs on phosphorylation of S6 protein and transferrin uptake. 
Means ± standard deviation (n = 2 experiments). (f) Inhibition of mTOR signaling by rapamycin (20 nM, 24 h) preferentially affects transferrin uptake when 
compared to DiI-labeled LDL or Alexa Fluor 488-labeled EGF. Average vesicular fluorescence intensities were measured. Mean ± SEM (n = 6 replicates).R142.8 Genome Biology 2007,     Volume 8, Issue 7, Article R142       Galvez et al. http://genomebiology.com/2007/8/7/R142
Genome Biology 2007, 8:R142
mTOR controls transferrin uptake by regulation of the number of transferrin receptors per vesicle and not endocytosis or recycling rates Figure 4
mTOR controls transferrin uptake by regulation of the number of transferrin receptors per vesicle and not endocytosis or recycling rates. (a) Effect of 
rapamycin on the time-course of fluorescent transferrin endocytosis (left) and recycling (right). Means ± standard error of the mean (SEM; n = 4 
replicates). (b) Lack of effect of rapamycin on the rate constants for endocytosis and recycling. The rate constants, tau-1, were calculated from a single 
exponential fit of the time-course data. (c) Effect of the PtdIns(3,4,5)P3-mTOR-targeting d-siRNAs on the number of transferrin receptors (TFRC) per cell 
(measured by immunofluorescence on permeabilized cells). Means ± SEM (n = 4). (d) Correlation between transferrin uptake (F, vertical axis) and 
transferrin receptor numbers (immunofluorescence measurements on permeabilized cells, horizontal axis) in HeLa cells in which PtdIns(3,4,5)P3-mTOR 
regulators were silenced. Means ± SEM (n = 4). (e) Selective effect of rapamycin on transferrin receptor staining (TFRC) compared to tubulin and actin 
staining. Means ± SEM (n = 6 replicates). (f) Rapamycin preferentially reduces the number of transferrin molecules per vesicles. Histogram of the relative 
transferrin fluorescence intensity per vesicle for control (CTR) and rapamycin (RAPA)-treated cells. Means ± SEM (n = 6 replicates). Inset shows the 
average intensity measured for the 30 brightest vesicles per cell. (g) Rapamycin has only a minor effect on the number of endocytic vesicles. Bar diagram 
shows means ± SEM (n = 6 replicates).
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lowing day using Gene Silencer (Genlantis; San Diego, CA,
USA) according to the manufacturer's protocol. Two and a
half days after transfection, cells were washed twice with
warmed DMEM/HEPES and incubated with 5 μg/ml Alexa
Fluor® 594-labelled holotransferrin (Invitrogen) for 10 min-
u t e s  a t  3 7 ° C  w i t h  5 %  C O 2. Surface-bound transferrin was
stripped off with a 1 minute incubation in NaCl (500 mM)/
acetic acid (200 mM). Following pH neutralization with
phosphate-buffered saline, cells were fixed with 4% formalde-
hyde and nuclei stained with Hoechst.
Time-courses of transferrin uptake (Figures 1d and 4a) were
determined as indicated above but transferrin accumulation
was stopped at the indicated time. For recycling experiments,
cells were first loaded with fluorescent transferrin (5 μg/ml)
for 30 minutes at 37°C and then washed and incubated with
non-fluorescent transferrin (50 μg/ml) for the indicated
times. The rate constants, tau, were calculated from single
exponential fits of the time-course data.
LDL and EGF uptake assays
HeLa cells were incubated with DiI-LDL (1 μg/ml; Invitro-
gen) or biotinylated EGF in complex with Alexa Fluor® 488
streptavidin (200 ng/ml of complex is equivalent to 15 ng/ml
of EGF; Invitrogen) for 30 minutes before surface stripping
and fixation.
Immunofluorescence staining
Formaldehyde fixed HeLa cells were permeabilized with 0.1%
Triton X100, blocked with 10% goat serum and 2% bovine
serum albumin and stained with anti-TFRC antibody (5 μg/
ml; M-A712, BD Pharmingen; San Diego, CA, USA), anti-
actin antibody (1:200; MAB1501, Chemicon International;
Temecula, CA, USA), anti-β-tubulin-Cy3 antibody (1:200;
Sigma; St. Louis, MO, USA) or anti-phosphorylated (S235/
236) ribosomal S6 protein (1:200; Cell Signaling Technology;
Danvers, MA, USA) associated with appropriate secondary
antibodies (Invitrogen).
Automated image acquisition and processing
Images were acquired on the ImageXpress 5000A automated
epifluorescence microscope (Molecular Devices; Sunnyvale,
CA, USA) using an ELWD 20×/0.45 Plan Fluor objective and
a 1,280 × 1,024 pixels cooled CCD camera with 12-bit readout.
Thirteen pairs of images (Hoechst and Alexa Fluor® 594
channels) were acquired per well. Image analysis was per-
formed using the ImageXpress database and software.
Images were corrected for non-uniform illumination and seg-
mented using the nucleus-associated Hoechst fluorescence.
Nuclear regions were then symmetrically expanded (+5 μm)
in order to include the perinuclear endosomal recycling com-
partment. For each detected cell, the background-subtracted
average intensities of the perinuclear regions were measured
in the Alexa Fluor® 594 channel. This method is independent
of the size of the cells but the size of nuclei might have influ-
enced the scoring but only slightly since average intensities
were considered. The scores of d-siRNAs strongly affecting
cell viability did not affect the final scoring since 'toxic' d-siR-
NAs were generally outliers (for example, KIF11/Eg5) or did
not score at all because the scores were calculated on few liv-
ing cells, which were not probably transfected. COPB1 and
ARCN1 affected cell viability but were considered as hits
because transferrin internalization was greatly reduced even
in the remaining cells.
For immunostaining, intensities integrated over the entire
cell area were used to estimate the total amount of TFRC, as
well as the total amount of actin or tubulin per cell. These
values were extracted automatically in two steps: first,
nuclear regions were expanded (+20 μm) in order to include
the entire cells; and second, expanded regions were shrunk to
fit the cell perimeters (using the antibody-associated intensi-
ties to threshold the images). The resulting cell areas were
used to calculate single cell integrated intensities. To compare
transferrin, LDL and EGF uptake, a texture detection algo-
rithm implemented in the ImageXpress 1.0 software suite
was used to identify fluorescent punctuate structures and to
estimate the vesicular density per cell, as well as the average
vesicle intensity. Single cell, average phospho-S6 immunoflu-
orescence intensity was measured in a 3 μm ring around cell
nuclei.
Analysis of the relative number of transferrin 
molecules per vesicle
For the results presented in Figure 4f,g, a Gaussian filter
adjusted for an average vesicle diameter of 2.2 pixels was used
to subtract a local background intensity of each transferrin
containing vesicle. The average of five pixel intensity values
was used as a measure of the intensity of transferrin-loaded
vesicles. The 30 brightest vesicles per cell were used for anal-
ysis. Rapamycin treatment reduced the average intensity of
these 30 brightest vesicles by 25%. This was used to adjust the
relative intensity threshold used for counting the number of
vesicles in the control case as well as for the rapamycin
treated cells.
Estimation of the number of hits in the primary screen: 
CAsH analysis
The experimental noise distribution was estimated using the
distribution of the deviations of the duplicated F values. The
data distribution fdata(x) was derived from the histogram of
the experimental F values averaged with a low-pass filter
(width = 2 × standard deviations of the noise). The noise dis-
tribution fnoise(x) was subtracted from the data distribution
fdata(x) to create the hit distribution fhit(x). CAsH was defined
as ±fhit(x)/fdata(x) to give an estimate of the expected fraction
of hits for each F value; a sign was added to indicate that a hit
is a suppressor (-) or an enhancer (+) (if 0 ≤ F < 1 ≥ CAsH ≤ 0;
if 1 ≤ F ≥ CAsH > 0).R142.10 Genome Biology 2007,     Volume 8, Issue 7, Article R142       Galvez et al. http://genomebiology.com/2007/8/7/R142
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Statistical analysis
P values were based on two-tailed homoscedatic Student's t-
distributions and reflect a comparison of control versus indi-
cated siRNA, or control versus rapamycin treatment. The
estimate for the off-target probability was based on the 10%
hit rate of the initial screen, approximately 183/1,804. Hits
occurred approximately 5% of the time in a given direction
(increase versus decrease). Assuming that all the hits are off-
target effects (worst case scenario), the upper boundary for
off-target effects from the screen becomes 5% and the proba-
bility for two independent siRNAs to both be off-target and go
in the same direction is therefore expected to be less than
0.25%.
Additional data files
The following additional data is available with the online ver-
sion of this manuscript. Additional data file 1 contains Figure
S1 to S5: Figure S1 illustrates the observed well-to-well varia-
bility in the transferrin uptake assay. HeLa cells were trans-
fected with CTR d-siRNA (targeting yellow fluorescent
protein, eYFP) or d-siRNA targeting the AP2M1 gene. Twelve
wells within the same row of a 96-well plate were transfected
with the same pool of d-siRNAs to measure the well-to-well
variability of the intensity measurements. Means ± standard
deviation of two experiments are represented. Figure S2 sum-
marizes the strategy used to generate the diced-siRNA
library. Specific primers for the selected genes were designed
to amplify approximately 600 bp PCR fragments from a
cDNA library. A second amplification was performed with a
set of nested primers bearing a T7 promoter sequence exten-
sion. Nested PCR products were in vitro transcribed, result-
ing double-stranded RNAs were diced with recombinant
enzyme Dicer and the 21 mers d-siRNAs were finally purified
from incomplete digests. Figure S3 shows the relationship
between duplicated values of F for the 1,920 screened d-siR-
NAs (red). The data are compared to a simulated, two-dimen-
sional Normal distribution of the stochastic noise (blue). The
estimated standard deviation of the noise distribution is
based on the measured deviations between duplicated meas-
urements for the same d-siRNA. Figure S4 shows the distri-
bution of the CAsH scores from the primary screen. The
population of genes with CAsH >0.95 are indicated in red.
Figure S5 is an example of the images used for quantitative
analysis. (a) Images of HeLa cells illustrating the effect of d-
siRNAs targeting mTOR (diced-mTOR) or GL3 luciferase
(CTR) on fluorescent transferrin (red) uptake, as well as the
effect of 24 h treatment with rapamycin (RAPA) compared to
DMSO (CTR). Scale bars: 20 μm. Insets show a magnified
view of the indicated image subset. (b) Immunofluorescent
staining (green) of transferrin receptor performed on perme-
abilized cells in order to estimate the total number of transfer-
rin receptors. Examples of cells transfected with d-siRNAs
targeting mTOR, TSC2 or GL3 luciferase (CTR). Scale bars, 10
μm. Insets show a magnified view of the indicated image sub-
set. Additional data file 2 is the list of the genes targeted by the
human d-siRNA signaling library. Additional data file 3 is the
list of hits from the primary screen. Additional data file 4 is
the list of the 21 identified 'high confidence' genes that
increase or decrease transferrin uptake in HeLa cells. Addi-
tional data file 5 contains the nucleotide sequences of the
designed external (outer) and nested primers for creating
Dicer siRNAs targeting 1,920 signaling proteins. Additional
data file 6 contains the nucleotide sequences of the designed
primers for the two independent sequences used to target the
21 high confidence hits as well as the sequences of the
expected amplicons.
Additional data file 1 Supplementary figures S1-S5 Figure S1 illustrates the observed well-to-well variability in the  transferrin uptake assay. HeLa cells were transfected with CTR d- siRNA (targeting yellow fluorescent protein, eYFP) or d-siRNA tar- geting the AP2M1 gene. Twelve wells within the same row of a 96- well plate were transfected with the same pool of d-siRNAs to  measure the well-to-well variability of the intensity measurements.  Means ± standard deviation of two experiments are represented.  Figure S2 summarizes the strategy used to generate the diced- siRNA library. Specific primers for the selected genes were  designed to amplify approximately 600 bp PCR fragments from a  cDNA library. A second amplification was performed with a set of  nested primers bearing a T7 promoter sequence extension. Nested  PCR products were in vitro transcribed, resulting double-stranded  RNAs were diced with recombinant enzyme Dicer and the 21 mers  d-siRNAs were finally purified from incomplete digests. Figure S3  shows the relationship between duplicated values of F for the 1,920  screened d-siRNAs (red). The data are compared to a simulated,  two-dimensional Normal distribution of the stochastic noise  (blue). The estimated standard deviation of the noise distribution  is based on the measured deviations between duplicated measure- ments for the same d-siRNA. Figure S4 shows the distribution of  the CAsH scores from the primary screen. The population of genes  with CAsH >0.95 are indicated in red. Figure S5 is an example of  the images used for quantitative analysis. (a) Images of HeLa cells  illustrating the effect of d-siRNAs targeting mTOR (diced-mTOR)  or GL3 luciferase (CTR) on fluorescent transferrin (red) uptake, as  well as the effect of 24 h treatment with rapamycin (RAPA) com- pared to DMSO (CTR). Scale bars: 20 μm. Insets show a magnified  view of the indicated image subset. (b) Immunofluorescent stain- ing (green) of transferrin receptor performed on permeabilized  cells in order to estimate the total number of transferrin receptors.  Examples of cells transfected with d-siRNAs targeting mTOR,  TSC2 or GL3 luciferase (CTR). Scale bars, 10 μm. Insets show a  magnified view of the indicated image subset. Click here for file Additional data file 2 Genes targeted by the human d-siRNA signaling library Genes targeted by the human d-siRNA signaling library. Click here for file Additional data file 3 Hits from the primary screen Hits from the primary screen. Click here for file Additional data file 4 The 21 identified 'high confidence' genes that increase or decrease  transferrin uptake in HeLa cells The 21 identified 'high confidence' genes that increase or decrease  transferrin uptake in HeLa cells. Click here for file Additional data file 5 Nucleotide sequences of the designed external (outer) and nested  primers for creating Dicer siRNAs targeting 1,920 signaling  proteins Nucleotide sequences of the designed external (outer) and nested  primers for creating Dicer siRNAs targeting 1,920 signaling  proteins. Click here for file Additional data file 6 Nucleotide sequences of the designed primers for the two inde- pendent sequences used to target the 21 high confidence hits as well  as the sequences of the expected amplicons Nucleotide sequences of the designed primers for the two inde- pendent sequences used to target the 21 high confidence hits as well  as the sequences of the expected amplicons. Click here for file
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